Literature DB >> 16434277

Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.

Soren Schenk1, Patrick M McCarthy, Eugene H Blackstone, Jingyuan Feng, Randall C Starling, Jose L Navia, Lingmei Zhou, Katherine J Hoercher, Nicholas G Smedira, Kiyotaka Fukamachi.   

Abstract

OBJECTIVES: Because duration of inotropic support after left ventricular assist device implantation has been recognized as a surrogate for right ventricular dysfunction, we sought to (1) identify its preimplantation risk factors, particularly its association with preimplantation right ventricular dysfunction, and (2) assess its impact on clinical outcomes.
METHODS: Between 1991 and 2002, left ventricular assist devices were implanted in 207 patients, exclusive of those receiving preoperative mechanical circulatory support, which precluded measuring right ventricular stroke work. Duration of inotropic support was analyzed as a continuous variable, truncated by death or transplantation, and in turn as a risk factor for these 2 events.
RESULTS: Inotropic support decreased from 100% on the day of implantation to 57%, 33%, and 22% by days 7, 14, and 21. Its duration was strongly associated with lower preimplantation right ventricular stroke work index, older age, and nonischemic cardiomyopathy and was associated (P < .04) with higher mortality before transplantation but not with transition to transplantation. We identified no preimplantation risk factors for right ventricular assist device use because of its relatively infrequent use in this population (18 patients, only 4 of whom survived to transplantation).
CONCLUSION: Duration of inotropic support after left ventricular assist device insertion is strongly correlated with low preimplantation right ventricular stroke work index. In turn, it was associated with reduced survival to transplantation. Thus, right ventricular stroke work measured before implantation might be useful in decision making for biventricular support, destination therapy, or total artificial heart.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434277     DOI: 10.1016/j.jtcvs.2005.09.031

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

Review 1.  Imaging in patients after cardiac transplantation and in patients with ventricular assist devices.

Authors:  Bhanu Gupta; Dany Jacob; Randall Thompson
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

Review 2.  Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.

Authors:  Christopher W Jensen; Andrew B Goldstone; Y Joseph Woo
Journal:  Curr Heart Fail Rep       Date:  2016-06

Review 3.  Right heart failure post left ventricular assist device implantation.

Authors:  Mihalis Argiriou; Styliani-Maria Kolokotron; Timothy Sakellaridis; Orestis Argiriou; Christos Charitos; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Machairiotis; Theodora Tsiouda; Kosmas Tsakiridis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

4.  Left Ventricular Assist Devices in the Management of Heart Failure.

Authors:  Edo Y Birati; Mariell Jessup
Journal:  Card Fail Rev       Date:  2015-04

5.  Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.

Authors:  Koichi Toda; Tomoyuki Fujita; Osamu Seguchi; Masanobu Yanase; Takeshi Nakatani
Journal:  J Artif Organs       Date:  2017-09-04       Impact factor: 1.731

6.  Right ventricular function and left ventricular assist device placement: clinical considerations and outcomes.

Authors:  Romeo Lainez; Gene Parrino; Michael Bates
Journal:  Ochsner J       Date:  2010

Review 7.  Mechanical bridge to decision: what are the options for the management of acute refractory cardiogenic shock?

Authors:  Daniel Goldstein; Siyamek Neragi-Miandoab
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 8.  Implantable continuous-flow right ventricular assist device: lessons learned in the development of a cleveland clinic device.

Authors:  Kiyotaka Fukamachi; Akira Shiose; Alex L Massiello; David J Horvath; Leonard A R Golding; Sangjin Lee; Randall C Starling
Journal:  Ann Thorac Surg       Date:  2012-03-27       Impact factor: 4.330

9.  Development of DexAide right ventricular assist device: update II.

Authors:  Kiyotaka Fukamachi; Diyar Saeed; Alex L Massiello; David J Horvath; Hideyuki Fumoto; Tetsuya Horai; Roula Zahr; Shanaz Shalli; Tomohiro Anzai; Raymond Dessoffy; Jacquelyn Catanese; Ji-Feng Chen; Qun Zhou; Stephen Benefit; Sue Alfini; Leonard A R Golding
Journal:  ASAIO J       Date:  2008 Nov-Dec       Impact factor: 2.872

10.  The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates.

Authors:  Jennifer Cowger Matthews; Todd M Koelling; Francis D Pagani; Keith D Aaronson
Journal:  J Am Coll Cardiol       Date:  2008-06-03       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.